News – Global Series Europe / Registration now open

Posted: August 16th, 2017

The registration for the Global Series Europe (25-26 September 2017 in London) is now opened to individuals. To engage serious dialogue, join corporate policy and legal leaders, government representatives in trade and intellectual property, trade and patent adjudicators, patent office leaders, and others. Participants include judges of the Federal Circuit, the United States District Courts, […]


NL – SPC Trastuzamab emtansine (Kadcyla)

Posted: August 9th, 2017

Legal entity [X] v. The Dutch Patent Office, District Court The Hague, 19 July 2017, Case No. ECLI:NL:RBDHA:2017:8031 Court appeal against the decision of the Dutch Patent Office to refuse to grant an SPC for trastuzamab emtansine. The Court agrees with the Dutch Patent Office that Article 3 first part and under a of SPC […]


NL – Pfizer v. Dutch Minister of Health / First and Second medical indication – Pricing

Posted: August 8th, 2017

Pfizer v. Dutch Minister of Health, Dutch Trade and Industry Appeals Tribunal (CBb), 7 July 2017, Case No. ECLI:NL:CBB:2017:249 Law on Pricing of Medicines. The Dutch Minister of Health sets maximum prices for medicines based on the prices of medicines in 4 reference states. In the current case, Pfizer appeals the pricing decision at the […]


NL – Smart Technologies v. CTouch Europe

Posted: August 1st, 2017

Smart Technologies ULC v. CTouch Europe B.V., District Court The Hague, 26 July 2017, Case No. ECLI:NL:RBDHA:2017:8247 Smart Technologies is the holder of a patent on smart television screens. CTouch’s Gillette defence fails as there is a theoretic and practical difference between its products and the prior art. Injunction and ancillary claims awarded. A copy […]


NL – Mobile Sanitary Solutions v. TWT Verhuur

Posted: July 31st, 2017

Mobile Sanitary Solutions B.V. v. TWT Verhuur B.V., Summary Judge of the District Court of The Hague, 28 July 2017, Case No. ECLI:NL:RBDHA:2017:8486 Patent Holder Mobile Sanitary Solutions alleges infringement. TWT states that the patent invoked is invalid. In a preliminary ruling the summary judge agrees with TWT and holds that the patent is likely […]


NL – Millennium v. Teva

Posted: July 31st, 2017

Millennium Pharmaceuticals Inc. v. Teva Nederland B.V., Pharmachemie B.V., Teva Pharma B.V., Teva Pharmaceuticals Europe B.V. and Teva API B.V., Summary Judge of the District Court of The Hague, 25 July 2017, Case no. ECLI:NL:RBDHA:2017:8259 The present dispute concerns an alleged infringement of the rights of Millennium Pharmaceuticals Inc. (“Millennium”) as vested in the Dutch […]


DE – Abdichtsystem

Posted: July 26th, 2017

“Abdichtsystem”, BGH, 16 May 2017, Case X ZR 120/15, reported by Nadine Heiartz and Dominik Woll, Bardehle Pagenberg German Federal Court of Justice on claims for recall and removal in Germany in case of acts performed abroad  In the present judgment, the German Federal Court of Justice (»BGH«) found that sales completely performed abroad may […]


News – Global Series – September 2017 / Sponsoring opportunities

Posted: July 25th, 2017

Global Series, special session London, 25 and 26 September From the information letter: “Today, fundamental challenges are confronting commerce, trade, and intellectual property. Precisely because of those rapidly emerging challenges, Global Series 2017 Europe hosts a special session on September 25 and 26, 2017, in London. The Global Series pursues the interests of the justice […]


News – Research Handbook on Intellectual Property and the Life Sciences

Posted: July 21st, 2017

Research Handbook on Intellectual Property and the Life Sciences, Edited by Duncan Matthews, Professor of Intellectual Property Law, Queen Mary University of London, UK and Herbert Zech, Professor of Life Sciences Law and Intellectual Property Law, University of Basel, Switzerland From the blurb: “Intellectual property (IP) is a key component of the life sciences, one […]


NL – Swiss Pharma v. Biogen

Posted: July 17th, 2017

Swiss Pharma International v. Biogen MA Inc., District Court The Hague, the Netherlands, 12 July 2017, ECLI:NL:RBDHA:2017:7628 Biogen holds EP 1485127, which relates to the treatment of Multiple Sclerosis (“MS”). Swiss Pharma seeks to invalidate the Dutch part of the patent. Claims 1, 3 and 4 are invalidated due to lack of novelty as these […]